Thrive Acquisition Corporation
| IPO Proceeds, $M | $172.50M |
|---|---|
| IPO Date | Oct 21, 2021 |
| CEO | Charles Jobson |
| Left Lead | BTIG |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + (3) |
| IPO Sector |
Healthcare
Global health and wellness |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Closing Date | Jan 25, 2023 |
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
No credit card required
Sign in for more on Thrive Acquisition Corporation:
- Structure and cap table
- 7 directors & officers
- 7 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Charles Jobson | 61 | Chief Executive Officer and Director |
| Charles Urbain | 67 | Chief Operating Officer, Chief Financial Officer, and Director |
| Benjamin Kao | 45 | President and Director |
| Peter Roy | 65 | Director |
| James Macon | 45 | Director |
| Daniel Germain | 48 | Director |
| Peter Graham | 66 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
| BTIG | BR | 14,250,000 | units |
| I-Bankers Securities | 750,000 | ||
| 15,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Filings
| Sep 9, 2021 | Initial S-1 |
| Sep 29, 2021 |
Amended S-1
Sign In to view filing content. |
| Oct 20, 2021 |
PR announcing pricing of $150mm IPO
Sign In to view filing content. |
| Oct 22, 2021 |
424B4 IPO Prospectus
Sign In to view filing content. |
| Oct 25, 2021 |
PR announcing full over-allotment exercise
Sign In to view filing content. |
| Dec 7, 2021 |
8-K announcing separate trading of common shares and warrants
Sign In to view filing content. |
| Jan 18, 2023 |
8-K announcing liquidation and redemption of public shares
Sign In to view filing content. |